Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

DuPont Merck presents dual MMP/TNF-alpha-converting enzyme inhibitor

Sep. 12, 1997

RWJ-63556: dual COX-2/5-LO inhibitor effective in canine model of local inflammation

Sep. 12, 1997

IDEC licenses rights to novel antiinflammatory technology

Sep. 11, 1997

New hydroxamic acid compounds inhibiting TNF, PDE IV and/or MMPs

Sep. 11, 1997

Promising preliminary results obtained with Arthrovas in osteoarthritis

Sep. 10, 1997

Boehringer Mannheim prepares MMP inhibitors

Sep. 8, 1997

Anika completes phase III trial on Orthovisc

Sep. 4, 1997

New MMP and TNF inhibitor from Kanebo

Sep. 2, 1997

Hyalgan introduced in U.S. for osteoarthritis of the knee

Sep. 1, 1997

Pharos receives patent for novel method of controlling and treating inflammation

Aug. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...